For much of the last ten years falling global malaria rates have rightly been a cause for celebration. However, the World Health Organization’s annual malaria reports for the years 2017 and 2018 suggested that progress had stalled in many countries and that they were not likely to reach their morbidity and mortality targets for 2020.

World Malaria Day is our annual reminder that we need to intensify our efforts to reduce the intolerable burden of malaria in the low- and middle-income countries.

Approximately 92% of the estimated 219 million annual malaria cases are recorded in Africa where it is the poorest of the poor who are disproportionately affected.

LSTM works to break the cycle of poor health and poverty by addressing all aspects of malaria transmission and biology from genomic studies of the mosquitoes that transmit malaria to trials of novel therapeutics and transmission-blocking interventions.

This breadth of research is one of LSTM’s unique strengths as we, and our partners, are able to rapidly transfer basic science discoveries into field trials and implementation and onwards into policy and practice. Key to this process is our commitment to inclusive, multi-disciplinary collaborations which prioritise the involvement of early career researchers, the future research leaders.

Below is an overview of the interdisciplinary research and capacity development activities we undertake to support global efforts to eliminate malaria.